Novartis AG's Exforge More Effective Than Only Amlodipine
ZURICH, July 28 (Reuters) - Novartis AG's (NOVN.VX: Quote, Profile, Research, Stock Buzz) blood pressure drug Exforge lowers blood pressure in twice as many patients than when they are treated with amlodipine alone, the group said on Monday, citing a study.